{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:01:41Z","timestamp":1794916901571,"version":"4.9.1"},"reference-count":31,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,3,29]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess predictive factors for rheumatoid arthritis interstitial lung disease (RA-ILD) in two early rheumatoid arthritis (RA) inception cohorts with a focus on methotrexate (MTX) exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicentre prospective early RA inception cohort studies; the early RA study (ERAS) and the early RA network (ERAN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Secondary care, ERAS nine centres, ERAN 23 centres in England, Wales and Ireland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients with new diagnosis of RA, n=2701. Standardised data including demographics, drug therapies and clinical outcomes including the presence of RA-ILD were collected at baseline, within 3\u20136 months, at 12 months and annually thereafter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Primary outcome was the association of MTX exposure on RA-ILD diagnosis. Secondary outcomes were the association of demographic, comorbid and RA-specific factors on RA-ILD diagnosis and the association of MTX exposure on time to RA-ILD diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 92 eligible ILD cases, 39 occurred in 1578 (2.5%) MTX exposed and 53 in 1114 (4.8%) non-MTX exposed cases. The primary analysis of RA-ILD cases only developing after any conventional synthetic disease-modifying antirheumatic drug treatment (n=67) showed MTX exposure not to be associated with incident RA-ILD (OR 0.85,\u200995% CI 0.49 to 1.49, p=0.578) and a non-significant trend for delayed ILD diagnosis (OR 0.54,\u200995% CI 0.28 to 1.06, p=0.072). In an extended analysis including RA-ILD cases present at RA diagnosis (n=92), MTX exposure was associated with a significantly reduced risk of incident RA-ILD (OR 0.48, 95% CI 0.3 to 0.79, p=0.004) and longer time to ILD diagnosis (OR 0.41, 95% CI 0.23 to 0.75, p=0.004). Other independent baseline associations with incident RA-ILD were higher age of RA onset, ever smoking, male gender, rheumatoid nodules and longer time from first RA symptom to first outpatient visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MTX treatment was not associated with an increased risk of RA-ILD diagnosis. On the contrary, evidence suggested that MTX may delay the onset of ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-028466","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T09:57:04Z","timestamp":1557136624000},"page":"e028466","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":221,"title":["Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts"],"prefix":"10.1136","volume":"9","author":[{"given":"Patrick","family":"Kiely","sequence":"first","affiliation":[{"name":"Department of Rheumatology, St Georges University Hospitals NHS Foundation Trust, London, UK"},{"name":"Institute of Medical and Biomedical Education, St George\u2019s , University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Busby","sequence":"additional","affiliation":[{"name":"Center for Health Services and Clinical Research and Post Graduate Medicine, University of Hertfordshire, Hatfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Nikiphorou","sequence":"additional","affiliation":[{"name":"Department of Academic Rheumatology, King\u2019s College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Center for Health Services and Clinical Research and Post Graduate Medicine, University of Hertfordshire, Hatfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Academic Rheumatology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Creamer","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dixey","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Shrewsbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Young","sequence":"additional","affiliation":[{"name":"Center for Health Services and Clinical Research and Post Graduate Medicine, University of Hertfordshire, Hatfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,5,5]]},"reference":[{"key":"2025101814383906000_9.5.e028466.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210715"},{"key":"2025101814383906000_9.5.e028466.2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.069252"},{"key":"2025101814383906000_9.5.e028466.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.06.054"},{"key":"2025101814383906000_9.5.e028466.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.093690"},{"key":"2025101814383906000_9.5.e028466.5","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.15b25.x"},{"key":"2025101814383906000_9.5.e028466.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel253"},{"key":"2025101814383906000_9.5.e028466.7","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X15612250"},{"key":"2025101814383906000_9.5.e028466.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq035"},{"key":"2025101814383906000_9.5.e028466.9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9609016"},{"key":"2025101814383906000_9.5.e028466.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu165"},{"key":"2025101814383906000_9.5.e028466.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.27405"},{"key":"2025101814383906000_9.5.e028466.12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318289ce01"},{"key":"2025101814383906000_9.5.e028466.13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025101814383906000_9.5.e028466.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1269"},{"key":"2025101814383906000_9.5.e028466.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.5.446"},{"key":"2025101814383906000_9.5.e028466.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-002-0227-6"},{"key":"2025101814383906000_9.5.e028466.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.3.262"},{"key":"2025101814383906000_9.5.e028466.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"2025101814383906000_9.5.e028466.19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/art.38344","article-title":"Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts","volume":"66","author":"Nikiphorou","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025101814383906000_9.5.e028466.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq318"},{"key":"2025101814383906000_9.5.e028466.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken406"},{"key":"2025101814383906000_9.5.e028466.22","first-page":"579","article-title":"van\u2019 t Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists","volume":"20","author":"Van der Heijde","year":"1993","journal-title":"J Rheumatol"},{"key":"2025101814383906000_9.5.e028466.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"2025101814383906000_9.5.e028466.24","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K"},{"key":"2025101814383906000_9.5.e028466.25","first-page":"76","article-title":"Joint working group of British Society of Rheumatology, & Royal College of Physicians: guidelines and audit measures for the specialist supervision of patients with rheumatoid arthritis","volume":"26","year":"1992","journal-title":"J Roy Coll Phys Lond"},{"key":"2025101814383906000_9.5.e028466.26","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/key075.470","article-title":"246\u2003No evidence that pulmonary fibrosis is a complication of long term methotrexate use: 10 year follow up data of patients treated with methotrexate for inflammatory arthritis","volume":"57","author":"Dawson","year":"2018","journal-title":"Rheumatology"},{"key":"2025101814383906000_9.5.e028466.27","doi-asserted-by":"publisher","DOI":"10.1080\/03009740601153774"},{"key":"2025101814383906000_9.5.e028466.28","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s10067-018-4314-9","article-title":"Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival","volume":"37","author":"England","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2025101814383906000_9.5.e028466.29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis","volume":"36","author":"Rojas-Serrano","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025101814383906000_9.5.e028466.30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq135"},{"key":"2025101814383906000_9.5.e028466.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.07.004"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-028466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:38:50Z","timestamp":1760823530000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-028466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,5]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/bmjopen-2018-028466"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-028466","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2018-028466.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}